Posts

Showing posts with the label topoisomerase Cancer topoisomerase inhibitors topoisomerase2a

Topoisomerase Inhibitors in Cancer

Topoisomerases are nuclear enzymes involved in DNA replication, transcription, chromosomal segregation, and recombination. There are two types of topoisomerases found in all cells: type I enzymes that cut single-stranded DNA and type II enzymes that cut and pass double-stranded DNA. Topo2 is involved in endoreduplication as well as mitotic chromosomal segregation following replication. Inhibiting topo2 in cells may cause a cascade of events ranging from endoreduplication and polyploidy to cell death. Etoposide is employed as an anticancer drug by targeting the topo2-DNA complex, however, its induction of the DNA strand break-stable complex may result in chromosomal translocation and, ultimately, a particular kind of leukaemia. There are two types of topoisomerase 2 inhibitors. Class 1 chemicals, such as etoposide and doxorubicin, are known as classical poisons because they stabilise the DNA-Topo 2 complex by producing lesions with broken DNA strands and protein covalently bound to them...